(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.

NCT00801723 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Budesonide MMX 6 mg Tablet
DRUG: Placebo Tablet

Sponsor

Bausch Health Americas, Inc.